Tumor-activated prodrug compounds and treatment
Tumor-activated prodrug compounds and treatment
Tumor-associated peptides binding promiscuosly to human...
Tumor-associated peptides binding promiscuously to human...
Tumor-associated peptides binding promiscuously to human...
TWEAK as a therapeutic target for treating central nervous...
TWEAK receptor
Two gonadotropin releasing hormones and a method to isolate...
Two gonadotropin releasing hormones and a method to isolate...
Two new human DnaJ-like proteins
Two synthetic peptides for treatment and prevention of cancers
Type 2 cytokine receptor and nucleic acids encoding same
Type-1 ribosome-inactivating protein
Type-2 neurotensin receptor (NT-R2)
Type-specific opsonic antibodies evoked with a synthetic peptide
Tyr-Arg-vasopressin antagonists
Tyrosine derivatives
Ubiquitin and ubiquitin related molecules for treatment and...
Ulinastatin-containing suppository
Ultra pure hemoglobin solutions and blood-substitutes